Ivabradine
Composition
Contains Ivabradine Hydrochloride, commonly available in 5 mg and 7.5 mg tablets.
Indications
Used to reduce heart rate in patients with chronic heart failure and stable angina who are in sinus rhythm.
Side effects
Bradycardia, luminous phenomena (phosphenes), headache, dizziness, fatigue.
Precautions
Use cautiously in patients with conduction disorders, atrial fibrillation, or pacemakers.
Contraindications
Acute decompensated heart failure, sick sinus syndrome, severe hypotension, sinoatrial block, pacemaker dependence, hypersensitivity to Ivabradine.
Dosage and administration
Usually starts at 5 mg twice daily; dose adjusted based on heart rate (range 2.5–7.5 mg twice daily).
Countries
Exported globally
Available Forms
Oral tablets.